Revision as of 20:47, 5 May 2010

Bibliography

American Society of Law, Medicine & Ethics, Inc., and Boston University American Journal of Law & Medicine, 2009, 35 Am. J. L. and Med.:
- Highlights
Follow-On Biologics: Intellectual Property and Innovation Issues

introduces innovation policy issues pertaining to follow-on biologics. @http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf

@www.ftc.gov/os/2009/06/P083901biologicsreport.pdf

@@ Line 1: / Line 1: @@
 {{TOCright}}
-= [[Vaccines/Glossary|Research Vocabulary]] =
-=Structured Rational for the Paper=
-# [[Vaccines/The_Argument_Framework|The Argument Framework]]
-=Study of the field=
-Analysis of the field with basis on [https://cyber.law.harvard.edu/commonsbasedresearch/Field_Research_Methodology Field Research Methodology]
-# [[Overview of Economics of Intellectual Property in Vaccines]]
-# [[Give an overall picture of the Vaccines' sector]]
-# Outputs and Products of the field: [[data, narratives and tools produced by the Vaccines' sector]]
-# Legal tools available for and in use by the actors of Vaccines' sector: [[IP in Vaccines]]
-# [[competitive advantages in Vaccines]]
-# [[IP Profile of Biggest for-profit companies in Vaccines]]
-# [[IP Profile of non-profit companies in Vaccines]]
-# [[IP Profile of Universities working in Vaccines]]
-# [[IP Profile of Associations in Vaccines]]
-# [[Commons based cases in Vaccines]]
-# [[Peer-Production Business models in Vaccines]]
-# [[Open Business models in Vaccines]]
 =[[Vaccines/Bibliography|Bibliography]]=
 *'''American Society of Law, Medicine & Ethics, Inc., and Boston University American Journal of Law & Medicine, 2009, 35 Am. J. L. and Med.:'''